A high proportion of SPP1+ macrophages was associated with genome instability and mutation (DNA mismatch repair deficiency, high levels of microsatellite instability, and high tumor mutation burden) in CRC (Fig. S6A–F), indicating that they could benefit from immunotherapy. This evidence concerns the gene SPP1 and colorectal carcinoma.